This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bioverativ Therapeutics Inc.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: **Nikhil Gandhi: Innovator in Device Container Technologies**
Introduction
Nikhil Gandhi, an inventor based in Holliston, MA, is making significant strides in the field of therapeutic device containers. With a total of three patents to his name, Gandhi is recognized for his innovative contributions that enhance the usability and functionality of medical kits.
Latest Patents
Gandhi's most recent patents focus on a novel design for device containers. These containers are specifically intended for therapeutic kits and feature a unique construction. In one embodiment, his device container includes:
- A first member designed to releasably hold a syringe barrel,
- A second member that securely holds a vial, coupled to the first member by a first hinge,
- A third member that holds a vial adapter, connected to the second member by a second hinge.
This innovative approach aims to improve the efficiency and safety of medical procedures involving syringes and vials.
Career Highlights
Nikhil Gandhi currently works with Bioverativ Therapeutics Inc., where he applies his expertise in developing cutting-edge solutions for therapeutic devices. His work focuses on creating practical solutions that meet the needs of healthcare professionals and patients alike.
Collaborations
Throughout his career, Gandhi has collaborated with notable colleagues such as Christine P. Janson and Ethan B. Jacoby. These partnerships have likely contributed to the innovation and refinement of his patented designs.
Conclusion
Nikhil Gandhi stands out as a significant figure in the realm of medical technology innovations. With his focus on enhancing therapeutic device containers, he is poised to make a lasting impact in the healthcare sector. His continued work at Bioverativ Therapeutics Inc. is expected to drive further advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile